Procter & Gamble Health Limited (BOM:500126)
India · Delayed Price · Currency is INR 5,205.85
+44.45 (0.86%)
At close: Oct 16, 2026
Procter & Gamble Health Market Cap
Procter & Gamble Health has a market cap or net worth of 86.41 billion as of October 16, 2026. It is the 10,683rd most valuable company in the world and the 642nd biggest in India. Its market cap has decreased by 15.61% in one year.
Market Cap
86.41B
Enterprise Value
84.65B
Revenue
14.33B
Global Rank
Country Rank
#642 India
PE Ratio
27.41
ChartMarket Cap Chart
Since June 14, 1999, Procter & Gamble Health's market cap has increased from 9.75B to 86.41B, an increase of 786.68%. That is a compound annual growth rate of 8.30%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 86.41B | -8.69% |
| Dec 31, 2025 | 94.63B | 8.85% |
| Dec 31, 2024 | 86.94B | 5.90% |
| Dec 29, 2023 | 82.10B | 23.12% |
| Dec 30, 2022 | 66.69B | -24.14% |
| Dec 31, 2021 | 87.91B | -22.28% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Caplin Point Laboratories | 175.06B |
| Jubilant Pharmova | 148.59B |
| AstraZeneca Pharma India | 148.07B |
| Viyash Scientific | 98.55B |
| Bliss GVS Pharma | 69.75B |
| Morepen Laboratories | 68.82B |
| Sanofi India | 68.11B |
| FDC Limited | 57.19B |